ReviewOxidative medicine and cellular longevity2017

Recent Advances and Challenges of mTOR Inhibitors Use in the Treatment of Patients with Tuberous Sclerosis Complex.

Filipe Palavra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.